Land: Vereinigte Staaten
Sprache: Englisch
Quelle: NLM (National Library of Medicine)
DIMENHYDRINATE (UNII: JB937PER5C) (DIPHENHYDRAMINE - UNII:8GTS82S83M, 8-CHLOROTHEOPHYLLINE - UNII:GE2UA340FM)
Strategic Sourcing Services LLC
ORAL
OTC DRUG
Antiemetic for prevention and treatment of these symptoms associated with motion sickness: - nausea - vomiting - dizziness
OTC monograph final
MOTION SICKNESS- DIMENHYDRINATE TABLET STRATEGIC SOURCING SERVICES LLC ---------- SUNMARK 44-198 DELISTED _ACTIVE INGREDIENT (IN EACH TABLET)_ Dimenhydrinate 50 mg _PURPOSE_ Antiemetic _USES_ for prevention and treatment of these symptoms associated with motion sickness: nausea vomiting dizziness _WARNINGS_ DO NOT USE for children under 2 years of age unless directed by a doctor. ASK A DOCTOR BEFORE USE IF YOU HAVE a breathing problem such as emphysema or chronic bronchitis glaucoma difficulty in urination due to enlargement of the prostate gland ASK A DOCTOR OR PHARMACIST BEFORE USE IF YOU ARE taking sedatives or tranquilizers. WHEN USING THIS PRODUCT alcohol, sedatives, and tranquilizers may increase drowsiness marked drowsiness may occur use caution when driving a motor vehicle or operating machinery avoid alcoholic beverages IF PREGNANT OR BREAST-FEEDING, ask a health professional before use. KEEP OUT OF REACH OF CHILDREN. In case of overdose, get medical help or contact a Poison Control Center right away. _DIRECTIONS_ to prevent motion sickness, the first dose should be taken one-half to one hour before starting activity adults and children 12 years and over 1 to 2 tablets every 4-6 hours; do not exceed 8 tablets in 24 hours, or as directed by a doctor children 6 to under 12 years ½ to 1 tablet every 6-8 hours; do not exceed 3 tablets in 24 hours, or as directed by a doctor children 2 to under 6 years ½ tablet every 6-8 hours; do not exceed 1½ tablets in 24 hours, or as directed by a doctor _OTHER INFORMATION_ EACH TABLET CONTAINS: calcium 35 mg TAMPER EVIDENT: DO NOT USE IF OUTER PACKAGE IS OPENED OR BLISTER IS TORN OR BROKEN store at 25ºC (77ºF); excursions permitted between 15º-30ºC (59º-86ºF) protect from moisture see end flap for expiration date and lot number _INACTIVE INGREDIENTS_ croscarmellose sodium, dibasic calcium phosphate dihydrate, magnesium stearate, microcrystalline cellulose, silicon dioxide, stearic acid _QUESTIONS OR COMMENTS?_ 1-800-426-9391 _PRINCIPAL DISPLAY PANEL_ SUNmark® * Lesen Sie das vollständige Dokument